
Integer Holdings Corporation ITGR
$ 97.5
0.97%
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
34.7 M |
Market Cap[1] |
$ 3.39 B |
EBITDA (LTM) |
$ 294 M |
P/E (LTM) |
42.71 |
P/S (LTM) |
1.64 |
EPS (LTM) |
2.01 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.76 | 0.17 % | $ 68.9 M | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Outset Medical
OM
|
$ 4.23 | 2.42 % | $ 64.3 K | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 39.73 | 0.91 % | $ 1.83 B | Nasdaq Capital Market,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Profound Medical Corp.
PROF
|
$ 6.85 | -2.0 % | $ 207 M | Nasdaq Global Select Market | ||
|
Insulet Corporation
PODD
|
$ 158.38 | -0.35 % | $ 11.1 B | Nasdaq Global Select Market,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 3.92 | 2.08 % | $ 167 M | Nasdaq Global Select Market,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Bruker Corporation
BRKR
|
$ 62.15 | 4.03 % | $ 9.43 B | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Tactile Systems Technology
TCMD
|
$ 27.44 | -0.65 % | $ 628 M | Nasdaq Global Select Market,SPB | ||
|
TELA Bio
TELA
|
$ 0.71 | -2.96 % | $ 33.3 M | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 16.9 | -0.06 % | $ 1.15 B | Nasdaq Global Market,SPB | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 0.92 | 0.75 % | $ 15.6 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Viemed Healthcare
VMD
|
$ 11.67 | -2.1 % | $ 454 M | Nasdaq Global Select Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.49 | -3.59 % | $ 410 M | Nasdaq Capital Market | ||
|
Beyond Air
XAIR
|
$ 5.47 | -4.37 % | $ 45.4 B | Nasdaq Global Select Market | ||
|
Avanos Medical
AVNS
|
$ 24.98 | - | $ 1.16 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.36 | -5.37 % | $ 22.4 M | Nasdaq Capital Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Inogen
INGN
|
$ 6.32 | -2.92 % | $ 168 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 6.62 | 0.15 % | $ 1.64 B | NYSE | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.